Blockchain Registration Transaction Record

Oragenics to Present at Sidoti Micro-Cap Virtual Investor Conference

Oragenics (OGEN) to present at Sidoti Micro-Cap Virtual Conference on May 21, 2026. Learn about its intranasal delivery platform and ONP-002 for concussion.

This news matters because it signals Oragenics' continued engagement with the investment community as it advances ONP-002, a potential breakthrough treatment for concussion and mild traumatic brain injury. With no FDA-approved treatments for concussion, Oragenics' intranasal delivery platform could revolutionize neurological care. For investors, this presents an opportunity to learn about a clinical-stage company targeting a large, underserved market. The Sidoti conference allows direct interaction with management, potentially influencing investment decisions.